Epidemiology, risk factors, and lifestyle modifications for gout
about
A pilot study of IL-1 inhibition by anakinra in acute goutPegloticase for chronic goutAssociation of three genetic loci with uric acid concentration and risk of gout: a genome-wide association studySerum uric acid and risk of multiple sclerosisGout--current diagnosis and treatmentOIT3 deficiency impairs uric acid reabsorption in renal tubuleSeasonal variation in acute gouty arthritis: data from Nationwide Inpatient Sample.The prevalence of rheumatic diseases in central Greece: a population survey.Mast Cells and MCPT4 Chymase Promote Renal Impairment after Partial Ureteral Obstruction.Management of hyperuricemia in gout: focus on febuxostat."Clinical features of women with gout arthritis." A systematic reviewEffects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men.Associations of non-high density lipoprotein cholesterol and traditional blood lipid profiles with hyperuricemia among middle-aged and elderly Chinese people: a community-based cross-sectional studyOverview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?Gout: a review of nonmodifiable and modifiable risk factors.Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout.New and improved strategies for the treatment of goutDeveloping potent human uric acid transporter 1 (hURAT1) inhibitorsContemporary epidemiology of gout in the UK general populationBidirectional Association between Self-Reported Hypertension and Gout: The Singapore Chinese Health Study.Total saponins from Discorea nipponica makino ameliorate urate excretion in hyperuricemic rats.Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study.A novel enzymatic approach in the production of food with low purine content using Arxula adeninivorans endogenous and recombinant purine degradative enzymes.Patient and clinical characteristics associated with gout flares in an integrated healthcare system.Silkworms can be used as an animal model to screen and evaluate gouty therapeutic drugsPotent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studiesTophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional surveyPresence of gout is associated with increased prevalence and severity of knee osteoarthritis among older men: results of a pilot studyAnemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study.Bidirectional Association between Diabetes and Gout: the Singapore Chinese Health Study.Food Sources of Protein and Risk of Incident Gout in the Singapore Chinese Health Study.Gout. Novel therapies for treatment of gout and hyperuricemia.Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective.Managing your patient with gout: a review of treatment options.Gouty arthritis: understanding the disease state and management options in primary care.Pegloticase: a novel agent for treatment-refractory gout.Hyperuricemia and gout: new concepts in diagnosis and management.Chronic gout in the elderly.Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.Association between ABCG2 Q141K polymorphism and gout risk affected by ethnicity and gender: a systematic review and meta-analysis.
P2860
Q21195421-62DD8EA8-945F-4A18-ABB5-9D8C4C16F5E9Q24236711-2121E62A-555E-4AA7-B92A-68175F154A22Q24318894-E1C75057-D87F-482E-9210-6EAE3DA243FCQ24632108-55169F8A-4265-40BB-856E-A2D5A3399EE2Q24644156-FE40FF1F-3E51-4EAD-BA89-CF394F098B92Q28509003-4C2EA8D4-4EB1-45E8-989A-706AAB378D83Q30985916-FB75E261-6626-4DBB-B668-B0829FCD3523Q33588016-548CAF56-1CD9-4701-81BE-B48E1A5F86D0Q33634028-8B5BBFB0-B9BC-47F9-BC00-A8CA2C901769Q33635542-4A8BE675-9A39-4D0F-BA54-946B539F9F14Q33812247-678C2CE3-48F2-42ED-BCF8-FB54B9824F76Q33875949-6C0C1E8F-7F0E-43B2-A10C-C31433C4DBFCQ33971640-0AF619A4-A7EB-4C6A-9D4E-B1ABEE4EC243Q34538414-29F793AA-92E6-48B0-ABFE-410EFDD125F0Q34609600-D7591440-D1AC-45C9-9978-FAFEC6DD794BQ34696782-CDE20FA3-BE75-42EB-B859-1674946B9EB6Q35026692-65A34549-BB8E-4BCB-8CA4-D05B3EAB8453Q35070747-083D074A-73E4-44AB-B396-8F65ACECA06BQ35092887-79C5CE4D-BCEB-45C2-9452-8B120B195D0FQ35824608-D3A2E13C-F547-4C82-BF7B-08ECBADF4B02Q35910341-CE393979-A142-403E-B342-A4A65A8BECC2Q36104398-09F2E0EA-7D01-40B3-B89B-22A62BE9E8E4Q36147138-D405BEF3-65CF-426C-8957-EF9D485A62D9Q36177440-68A24ADF-9FD8-4EC2-BC23-6273F8A873D4Q36305737-07B16F98-EE6F-4FF7-AC97-318694ECB247Q36393972-FDE17377-FE1F-4CDC-AA76-4525BE088436Q36402266-009C001C-1FCE-4A04-BED2-4A7C3141CABFQ36468332-78404542-D38E-4BF1-852D-7B7CF5306E26Q36633444-A9BA2851-3CF7-4167-AAE1-6856A1C28475Q36886192-CC9B52EC-3C73-4BC8-B0F9-AB7EB083779CQ37081271-0CA6C543-BB29-48F1-BECE-4EBA5954C7F8Q37350841-24168BD4-5401-48ED-BF35-C9E273BC6FC6Q37464024-CAEB18BD-3B81-4CF3-98A6-0B50C4D218B3Q37874889-45E1060D-4E98-46BD-95BE-19F551D3D29CQ37926938-B391CAF4-9B73-4783-8A85-40FCAAD2A570Q37991129-98203AED-8A1A-4408-B8C9-C4866CB19DD5Q38074338-DE81875F-67F7-4974-8E03-006E05F9A01CQ38112326-E5A7EBA5-6DA7-4D5B-8807-AB8097C89D37Q38234234-596699E3-D175-4D5C-B231-426AAA57FCD2Q38339494-3C7C8484-A94E-40DC-8517-0A0E1487114B
P2860
Epidemiology, risk factors, and lifestyle modifications for gout
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Epidemiology, risk factors, and lifestyle modifications for gout
@ast
Epidemiology, risk factors, and lifestyle modifications for gout
@en
Epidemiology, risk factors, and lifestyle modifications for gout
@nl
type
label
Epidemiology, risk factors, and lifestyle modifications for gout
@ast
Epidemiology, risk factors, and lifestyle modifications for gout
@en
Epidemiology, risk factors, and lifestyle modifications for gout
@nl
prefLabel
Epidemiology, risk factors, and lifestyle modifications for gout
@ast
Epidemiology, risk factors, and lifestyle modifications for gout
@en
Epidemiology, risk factors, and lifestyle modifications for gout
@nl
P2860
P3181
P356
P1476
Epidemiology, risk factors, and lifestyle modifications for gout
@en
P2093
Kenneth G Saag
P2860
P2888
P3181
P356
10.1186/AR1907
P407
P433
P478
P577
2006-04-12T00:00:00Z
P5875
P6179
1020974793